Sponsored Links

UCLA Researchers Reconstitute Enzyme That Synthesizes Cholesterol Drug Lovastatin PDF Print E-mail
Medical News - Cholesterol
Researchers from the UCLA Henry Samueli School of Engineering and Applied Science have for the first time successfully reconstituted in the laboratory the enzyme responsible for producing the blockbuster cholesterol-lowering drug lovastatin. The research, published Oct. 23 in the journal Science, could potentially lead to the development of other compounds with similarly beneficial effects.

Read more: Cholesterol News From Medical News Today